EXHIBIT- 12.1
Corvus Pharmaceuticals, Inc.
STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED SHARE DIVIDENDS
(In Thousands)
|
|
| ||||||||
|
| 2016 |
| 2015 |
| 2014 |
| |||
|
|
|
|
|
|
|
| |||
Fixed charges: |
|
|
|
|
|
|
| |||
Interest expense |
| $ | — |
| $ | — |
| $ | — |
|
Interest component of rentals (1) |
| 193 |
| 115 |
| — |
| |||
Total Fixed Charges |
| 193 |
| 115 |
| — |
| |||
|
|
|
|
|
|
|
| |||
Earnings available for fixed charges: |
|
|
|
|
|
|
| |||
Pre-tax income (loss) from continuing operations |
| (36,375 | ) | (31,335 | ) | (161 | ) | |||
Add: Fixed Charges |
| 193 |
| 115 |
| — |
| |||
Earnings (deficiency of earnings) available to cover fixed charges |
| $ | (36,182 | ) | $ | (31,220 | ) | $ | (161 | ) |
Ratio of earnings to fixed charges(2) |
| N/A |
| N/A |
| N/A |
| |||
(1) One third of rent expense was included in the calculation as it is a reasonable approximation of the interest factor.
(2) Our earnings were inadequate to cover fixed charges for the years ended December 31, 2016, 2015 and 2014.
